Formulation and evaluation of a dapsone and fexofenadine HCl immediate release combination tablet

Karkhile Shubhangi; Kasabe Amit; Barge Vijaya Sakpal Bhavana; Suryawanshi Parijat

doi:10.53730/ijhs.v6nS3.8244

Authors

Karkhile Shubhangi
Shubhangi3347@gmail.com
Department of Pharmaceutical Quality Assurance, PDEA’S Shankarrao Ursal College of Pharmaceutical Sciences & Research centre, Kharadi, Pune, Maharashtra, India
Kasabe Amit Department of Pharmaceutical Quality Assurance, PDEA’S Shankarrao Ursal College of Pharmaceutical Sciences & Research centre, Kharadi, Pune, Maharashtra, India
Barge Vijaya Sakpal Bhavana Department of Pharmaceutical Quality Assurance, PDEA’S Shankarrao Ursal College of Pharmaceutical Sciences & Research centre, Kharadi, Pune, Maharashtra, India
Suryawanshi Parijat Department of Pharmaceutical Quality Assurance, PDEA’S Shankarrao Ursal College of Pharmaceutical Sciences & Research centre, Kharadi, Pune, Maharashtra, India

Keywords:

dapsone, fexofenadine HCl, urticaria, immediate release, super disintegrant

Abstract

The purpose of the study was to formulate a conventional (immediate release) tablet using a combination of Dapsone and Fexofenadine HCl. Dapsone is a sulfone with anti-inflammatory, immunosuppressive, antibiotic, and antibacterial properties. Fexofenadine HCl is a non-sedating antihistamine approved for the treatment of allergies, whereas Dapsone is used to prevent bacteria from growing and causing red, itching welts. Fexofenadine HCl is an antihistamine that is used to treat allergic symptoms by blocking a natural substance called histamine. Direct compression methods were used to formulate the tablets, which contained super disintegrating polymers such as Ac-di-sol (Croscarmellose sodium). Four tablet formulations were compounded using the direct compression method, with polymer varying ratios. According to the evaluation results, formulations met the specifications when compared to official pharmacopoeias and standards. Different parameters, such as hardness, friability, weight variation, and dissolution studies, were used to evaluate tablets. This formulation of tablet combination of Dapsone and Fexofenadine HCl releases the drug within 60 minutes. Thus, the trial was a success in terms of achieving our goal of developing a tablet with few excipients and a simple manufacturing method.

Downloads

Download data is not yet available.

References

Patel HP, Patel JK, Patel RR; Formulation Development & Optimization of Multiple Unit Particles System (mups) Containing Ramipril and Hydrochlorothiazide. International Journal of Pharmaceutical Sciences, 2010; 2(1): 448- 456

Park K. Controlled drug delivery systems:past forward and future back. J Control Release 2014;190:3-8.

Homayun B, Lin X, Choi HJ. Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals. Pharmaceutics. 2019;11(3):129. Published 2019 Mar 19. doi:10.3390/pharmaceutics11030129.

Jadhav SB, Mali AD, Rajeghadage SH and Bathe ARS: Formulation and evaluation of immediate release tablets of Imipramine hydrochloride. International Journal of Biomedical and Advance Research 2014; 5(11): 559-65.

Patel N, Natarajan R and Rajendran NN: Formulation and evaluation of immediate release bilayer tablets of Telmisartan and Hydrochlorothiazide. International Journal of Pharmaceutical Sciences and Nanotechnology 2011; 4(3): 1477-82.

Jon Gabrielsson, Nils-Olof Lindberg and Torbjorn Lundstedt , Multivariate Methods in Pharmaceutical Applications, J.Chemom 2002; 16:141-160

Dedhiya et al, “Lercanidipine immediate release compositions” United States Patent Application 2006 0134212

Eriksson et al, “New oral immediate release dosage form” United States Patent Application 20060034 911

Poonawalla T, Kelly B. Urticaria : a review. Am J Clin Dermatol. (2009) 10:9–21. doi: 10.2165/0128071-200910010-00002

PubMed Abstract | CrossRef Full Text | Google Scholar

Kanani A, Betschel SD, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol. (2018) 14 (Suppl. 2):59. doi: 10.1186/s13223-018-0288-z

Powell RJ, Leech SC, Till S, Huber PA, Nasser SM, Clark AT, British Society for Allergy and Clinical Immunology. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015;45(3):547–65

Lee, E.E., Maibach, H.I. Treatment of Urticaria. Am J Clin Dermatol 2, 27–32 (2001). https://doi.org/10.2165/00128071-200102010-00005.

Mahdy AM, Webster NR. Pharmacology. Elsevier Ltd; 2011. Histamine and antihistamines; pp. 324–9.

Cartensen JT, Rhodes CT (2005) Preformulation. In: Cartensen JT, Rhodes CT (eds.). Drug Stability principles and practices (3rd edn)., Marcel Dekker Inc., New York, USA.

Maurya SD, Tilak VK, Dhakar RC, Verma KK, Soni U, Gupta, Preparation and evaluation of floating tablet of famotidine through solid dispersion, International Journal of Current Research and Review, 2011; (2)1: 21-30.

Thoke SB, Sharma Y., Rawat S, Nangude, SFormulation development & evaluation of effervescent tablet of Alendronate sodium with vitamin D3, Journal of Drug Delivery & Therapeutics; 2013; 3(5):65-74.

Tomar M, Singh AK, Sinha AR. Physical parameter of microcrystalline cellulose and the most acceptability in pharmaceutical industries: J of inno in p’ceutical and bio Sci., 2015; 570-578.

RaoNGR, Kumar M, Reddy MS, Kistayya C, Reddy BM. Development and evaluation of fast dissolving tablets of fosinopril by a sublimation method. Int J Pharm Sci Drug Res 2012;4:230-5.

Chavan PM and Ughade S: Preparation, characterization and evaluation of tablet for colonic delivery. Int J Pharm Sci & Res 2018; 9(5):2027-33. doi: 10.13040/IJPSR.0975-8232.9(5).2027-33.

Michaels A.S, ChandrasekaranS.K, Shaw J.E. Drug permeation through human skin: Theory and invitro experimental measurement. AIChE J. 2004;21(5) 16 Williams AC, Barry BW.Penetration enhancers.Adv drug deliv rev.2004;56(5):603-618.